Have a Claim?

Click here for a confidential contact or call:


January 19, 2016

Posted  January 19, 2016

New Jersey will receive a total of $2.7 million as a result of its participation in a global settlement with Qualitest Pharmaceuticals Inc. that resolves civil allegations the company mislabeled its multivitamin-with-fluoride tablets to indicate they were richer in fluoride than they actually were. Qualitest was the subject of a whistleblower lawsuit filed in 2013 by a Florida dentist who alleged that it unlawfully represented its multivitamin tablets as containing levels of fluoride recommended by the American Dental Association (ADA) when they did not. NJ

Tagged in: Pharma Fraud,